 Deutsche Bank AG decreased its position in shares of Ionis Pharmaceuticals Inc NASDAQ:IONS by 56.0 during the 1st quarter, according to the company in its most recent 13F filing with the Securities Exchange Commission. The institutional investor owned 148,130 shares of the companys stock after selling 188,452 shares during the quarter. Deutsche Bank AG ... 